Results 101 to 110 of about 211,160 (222)
The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids [PDF]
, 2010 Objective The aim of this study was to evaluate and compare both ovarian function and menstrual characteristics following uterine artery embolisation (UAE) and surgery. Design Subgroup of women from a randomised controlled trial.
D. Lyons +19 more
core +1 more source
International Journal of Cancer, Volume 159, Issue 7, Page 1588-1601, 1 October 2026.ABSTRACT The standard for assessing and recording the extent of the tumour, a necessity for most malignancies, is the Tumour Node Metastases (TNM) classification. The Union for International Cancer Control (UICC) TNM committee has defined this since the early 1950s.
James D. Brierley +8 more
wiley +1 more source
Mesothelin as Biomarker and Therapeutic Target for Immunotherapy in Cancer
MedComm, Volume 7, Issue 10, October 2026.Mesothelin overexpression activate important pathways like nuclear factor k‐light‐chain‐enhancer of activated B cells (NF‐κB) and interleukin‐6 (IL‐6). This in turn causes numerous cancers, such as pancreatic and ovarian cancers. MSLN‐targeting immunotherapies, like monoclonal antibodies, have shown efficacy.
Manoj Kumar Gupta +2 more
wiley +1 more source
Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 2068-2080, October 2026.This retrospective observational study compared clinical outcomes from patients who underwent transumbilical laparoendoscopic single‐site surgery (single‐site laparoscopy) or conventional multi‐port laparoscopy for myomectomy. Single‐site laparoscopy and multi‐port laparoscopy showed similar performance in terms of surgical safety.
Xu Yang +11 more
wiley +1 more source
Non-puerperal uterine inversion due to uterine sarcoma
, 2006 Background: Uterine inversion is a very rare pathological condition that usually occurs in puerperium. Non-puerperal uterine inversion is exceptional and to our knowledge only a few cases of uterine inversion due to a uterine sarcoma have been reported ...
SELVAGGI L. +4 more
core +1 more source
Diagnostic Pathology, 2019 Background Uterine leiomyomas, in contrast to sarcomas, tend to cease growth following menopause. In the setting of a rapidly enlarging uterine mass in a postmenopausal patient, clinical distinction of uterine leiomyoma from sarcoma is difficult and ...
Alessandra J. Ainsworth +9 more
doaj +1 more source
Cancer Science, Volume 117, Issue 10, Page 2803-2818, October 2026.Copy number variation analysis in The Cancer Genome Atlas identified NTAQ1 as a potential driver of HCC progression. NTAQ1 accelerates tumor growth by promoting the degradation of the tumor suppressor protein PRDM2, thereby impairing DNA repair and suppressing apoptosis. These findings indicate that NTAQ1 could be a valuable target for the treatment of
Tomohiko Ikehara +21 more
wiley +1 more source
Uterine sarcoma in young women – analysis of 17 cases [PDF]
, 2007 Uterine sarcoma are characterized by aggressive clinical course, poor prognosis and early development of metastases. According to various authors, they constitute 1-5% of all malignant uterine neoplasms.
Kellas-Ślęczka, Sylwia +5 more
core
The investigation of PD-L1 expression as a prognostic marker for uterine sarcoma
, 2018 Clinical medicine hopes for the development of reliable tumor markers, on the basis of which there can be chosen the optimal treatment program for uterine sarcoma patients, and also make a prognosis.
Zadnepryanniy, A. Z. +6 more
core +1 more source